Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol. 2012;8(7):420–9.

CAS  PubMed  Google Scholar 

Mota MT, et al. Complete genome sequence of Mayaro virus imported from the Amazon Basin to Sao Paulo State, Brazil. Genome Announc. 2015;3(6):e01341–15.

Mackay IM, Arden KE. Mayaro virus: a forest virus primed for a trip to the city? Microbes Infect. 2016;18(12):724–34.

PubMed  Google Scholar 

Brustolin M, Pujhari S, Henderson CA, Rasgon JL. Anopheles mosquitoes may drive invasion and transmission of Mayaro virus across geographically diverse regions. PLoS Negl Trop Dis. 2018;12(11):e0006895.

CAS  PubMed  PubMed Central  Google Scholar 

Tappe D, Pérez-Girón JV, Just-Nübling G, Schuster G, Gómez-Medina S, Günther S, et al. Sustained elevated cytokine levels during recovery phase of Mayaro virus infection. Emerg Infect Dis. 2016;22(4):750–2.

CAS  PubMed  PubMed Central  Google Scholar 

Assuncao-Miranda I, Cruz-Oliveira C, Da Poian AT. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. Biomed Res Int. 2013;2013:973516.

PubMed  PubMed Central  Google Scholar 

Mostafavi H, et al. Arthritogenic alphavirus-induced immunopathology and targeting host inflammation as a therapeutic strategy for alphaviral disease. Viruses. 2019;11(3):290.

•• Lidbury BA, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197(11):1585–93 This work demonstrated the role of macrophages and their mediators in alphaviral pathogenesis and guided further studies to understand how these factors work and in the development of therapies using these factors as targets. In addition, studies with different alphaviruses, including MAYV, have shown that these immune factors act similarly in the diseases induced by these alphaviruses.

CAS  PubMed  Google Scholar 

Rulli NE, Guglielmotti A, Mangano G, Rolph MS, Apicella C, Zaid A, et al. Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum. 2009;60(8):2513–23.

CAS  PubMed  Google Scholar 

Ng LFP. Immunopathology of Chikungunya virus infection: lessons learned from patients and animal models. Annu Rev Virol. 2017;4(1):413–27.

CAS  PubMed  Google Scholar 

Esposito DLA, Fonseca B. Will Mayaro virus be responsible for the next outbreak of an arthropod-borne virus in Brazil? Braz J Infect Dis. 2017;21(5):540–4.

PubMed  Google Scholar 

Weise WJ, Hermance ME, Forrester N, Adams AP, Langsjoen R, Gorchakov R, et al. A novel live-attenuated vaccine candidate for Mayaro fever. PLoS Negl Trop Dis. 2014;8(8):e2969.

PubMed  PubMed Central  Google Scholar 

Khan S, Khan A, Rehman AU, Ahmad I, Ullah S, Khan AA, et al. Immunoinformatics and structural vaccinology driven prediction of multi-epitope vaccine against Mayaro virus and validation through in-silico expression. Infect Genet Evol. 2019;73:390–400.

CAS  PubMed  Google Scholar 

Choi H, Kudchodkar SB, Reuschel EL, Asija K, Borole P, Ho M, et al. Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS Negl Trop Dis. 2019;13(2):e0007042.

CAS  PubMed  PubMed Central  Google Scholar 

Mota MTO, et al. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep. 2020;10(1):5306.

CAS  PubMed  PubMed Central  Google Scholar 

Izurieta RO, DeLacure DA, Izurieta A, Hoare IA, Reina Ortiz M. Mayaro virus: the jungle flu. Virus Adaptation and Treatment. 2018;10:9–17.

Google Scholar 

Aguilar-Luis MA, del Valle-Mendoza J, Silva-Caso W, Gil-Ramirez T, Levy-Blitchtein S, Bazán-Mayra J, et al. An emerging public health threat: Mayaro virus increases its distribution in Peru. Int J Infect Dis. 2020;92:253–8.

CAS  PubMed  Google Scholar 

Pinheiro FP, et al. An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings. Am J Trop Med Hyg. 1981;30(3):674–81.

CAS  PubMed  Google Scholar 

Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, et al. Hunting in the rainforest and Mayaro virus infection: an emerging alphavirus in Ecuador. J Glob Infect Dis. 2011;3(4):317–23.

PubMed  PubMed Central  Google Scholar 

Azevedo RS, et al. Mayaro fever virus, Brazilian Amazon. Emerg Infect Dis. 2009;15(11):1830–2.

PubMed  PubMed Central  Google Scholar 

Mourao MP, et al. Mayaro fever in the city of Manaus, Brazil, 2007-2008. Vector Borne Zoonotic Dis. 2012;12(1):42–6.

PubMed  PubMed Central  Google Scholar 

Neumayr A, Gabriel M, Fritz J, Günther S, Hatz C, Schmidt-Chanasit J, et al. Mayaro virus infection in traveler returning from Amazon Basin, northern Peru. Emerg Infect Dis. 2012;18(4):695–6.

PubMed  PubMed Central  Google Scholar 

Torres JR, Russell KL, Vasquez C, Barrera R, Tesh RB, Salas R, et al. Family cluster of Mayaro fever, Venezuela. Emerg Infect Dis. 2004;10(7):1304–6.

PubMed  PubMed Central  Google Scholar 

• Santos FM, et al. Animal model of arthritis and myositis induced by the Mayaro virus. PLoS Negl Trop Dis. 2019;13(5):e0007375 This paper describes a novel animal model designed for studying arthritis and myositis induced by Mayaro virus. In this study, it was possible to observe disease development and the main immune mediators related to pathogenesis.

CAS  PubMed  PubMed Central  Google Scholar 

Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, Babu RB, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115(2):287–91.

PubMed  Google Scholar 

Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, Sathe P. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol. 2007;144(4):552–6.

PubMed  Google Scholar 

Merle H, Donnio A, Jean-Charles A, Guyomarch J, Hage R, Najioullah F, et al. Ocular manifestations of emerging arboviruses: dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever. J Fr Ophtalmol. 2018;41(6):e235–43.

CAS  PubMed  Google Scholar 

• Halsey ES, et al. Mayaro virus infection, Amazon Basin region, Peru, 2010–2013. Emerg Infect Dis. 2013;19(11):1839–42 This work comprises a cohort study, in which patients infected by MAYV are followed for a long time. In this study, authors demonstrate that arthralgia can persist for a year and has a major impact on people’s life quality. It also shows the main affected joints.

PubMed  PubMed Central  Google Scholar 

Theilacker C, Held J, Allering L, Emmerich P, Schmidt-Chanasit J, Kern WV, et al. Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlates. BMC Infect Dis. 2013;13:369.

CAS  PubMed  PubMed Central  Google Scholar 

Hassing RJ, et al. Cross-reactivity of antibodies to viruses belonging to the Semliki forest serocomplex. Euro Surveill. 2010;15(23):19588.

•• Santiago FW, et al. Long-term arthralgia after Mayaro virus infection correlates with sustained pro-inflammatory cytokine response. PLoS Negl Trop Dis. 2015;9(10):e0004104 This cohort presents a complete panel of immune mediators elicited during Mayaro fever as well as a comparison between groups with different post-infection states.

PubMed  PubMed Central  Google Scholar 

Acosta-Ampudia Y, Monsalve DM, Rodríguez Y, Pacheco Y, Anaya JM, Ramírez-Santana C. Mayaro: an emerging viral threat? Emerg Microbes Infect. 2018;7(1):163.

PubMed  PubMed Central  Google Scholar 

Figueiredo ML, Figueiredo LT. Emerging alphaviruses in the Americas: Chikungunya and Mayaro. Rev Soc Bras Med Trop. 2014;47(6):677–83.

PubMed  Google Scholar 

Wang E, Paessler S, Aguilar PV, Carrara AS, Ni H, Greene IP, et al. Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections. J Clin Microbiol. 2006;44(11):4000–8.

CAS  PubMed  PubMed Central  Google Scholar 

Fumagalli MJ, et al. Development of an enzyme-linked immunosorbent assay to detect antibodies targeting recombinant envelope protein 2 of Mayaro virus. J Clin Microbiol. 2019;57(5):e01892–18.

Fischer C, et al. Robustness of serologic investigations for Chikungunya and Mayaro viruses following coemergence. mSphere. 2020;5(1)e00915–19.

Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol. 2006;80(2):737–49.

CAS  PubMed  PubMed Central  Google Scholar 

Gardner J, Anraku I, le TT, Larcher T, Major L, Roques P, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol. 2010;84(16):8021–32.

CAS  PubMed  PubMed Central  Google Scholar 

Soden M, Vasudevan H, Roberts B, Coelen R, Hamlin G, Vasudevan S, et al. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 2000;43(2):365–9.

CAS  PubMed  Google Scholar 

Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, et al. Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One. 2007;2(6):e527.

PubMed  PubMed Central  Google Scholar 

Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis. 2011;204(1):115–23.

CAS  PubMed  Google Scholar 

Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis. 2011;204(7):1026–30.

CAS  PubMed  Google Scholar 

Kumar S, Jaffar-Bandjee MC, Giry C, Connen de Kerillis L, Merits A, Gasque P, et al. Mouse macrophage innate immune response to Chikungunya virus infection. Virol J. 2012;9:313.

CAS  PubMed  PubMed Central  Google Scholar 

Cavalheiro MG, et al. Macrophages as target cells for Mayaro virus infection: involvement of reactive oxygen species in the inflammatory response during virus replication. An Acad Bras Cienc. 2016;88(3):1485–99.

CAS  PubMed  Google Scholar 

Teo TH, Lum FM, Claser C, Lulla V, Lulla A, Merits A, et al. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol. 2013;190(1):259–69.

CAS  PubMed  Google Scholar 

Burrack KS, Montgomery SA, Homann D, Morrison TE. CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice. J Immunol. 2015;194(2):678–89.